Cytodyn Inc (CYDY)

[Saltz]

I agree Misiu, it's not easy to find patients. Seen it many times when Bio's get to Phase 3 and protocol is approved and then enrollment stalls out. With the efficacy and safety established to date I think we will have an easier time of it. Another barrier is many have an issue with needles however if I was faced with the choices I would choose Pro-140 in a flash (and I have an issue with needles). Regardless we should be able to rapidly enroll 30 patients with 38 sites to work with.

I too am very optimistic given the success Nader has had working with the FDA. I have built a significant position and followed Nader and company closely for going on four years so my patience and confidence can be tested at times. I think we are six months away from data that can push us past the tipping point. Just nervous about progress getting bogged down in the FDA process. 2017 is going to tell the story.